Susquehanna International Group
VRTX icon

Susquehanna International Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Susquehanna International Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314M Buy
702,400
+113,300
+19% +$52.8M 0.04% 371
2025
Q4 		$267M Sell
589,100
-7,700
-1% -$3.32M 0.03% 437
2025
Q3 		$234M Buy
596,800
+114,200
+24% +$47.7M 0.03% 481
2025
Q2 		$215M Buy
482,600
+2,200
+0.5% +$1.01M 0.03% 438
2025
Q1 		$233M Buy
480,400
+13,100
+3% +$6.1M 0.04% 346
2024
Q4 		$188M Buy
467,300
+155,300
+50% +$72M 0.03% 444
2024
Q3 		$145M Buy
312,000
+18,100
+6% +$8.69M 0.03% 496
2024
Q2 		$138M Buy
293,900
+38,900
+15% +$16.9M 0.03% 475
2024
Q1 		$107M Sell
255,000
-274,500
-52% -$116M 0.02% 633
2023
Q4 		$215M Buy
529,500
+25,100
+5% +$9.27M 0.04% 362
2023
Q3 		$175M Buy
504,400
+197,100
+64% +$68.9M 0.04% 393
2023
Q2 		$108M Buy
307,300
+29,100
+10% +$9.8M 0.02% 568
2023
Q1 		$87.7M Sell
278,200
-44,500
-14% -$13.3M 0.02% 655
2022
Q4 		$93.2M Sell
322,700
-101,900
-24% -$31.1M 0.02% 576
2022
Q3 		$123M Buy
424,600
+58,700
+16% +$16.9M 0.03% 440
2022
Q2 		$103M Sell
365,900
-144,000
-28% -$38.5M 0.03% 510
2022
Q1 		$133M Sell
509,900
-39,400
-7% -$9.35M 0.02% 542
2021
Q4 		$121M Sell
549,300
-51,400
-9% -$9.99M 0.02% 643
2021
Q3 		$109M Sell
600,700
-261,800
-30% -$51.1M 0.01% 745
2021
Q2 		$174M Buy
862,500
+395,000
+84% +$82.6M 0.02% 558
2021
Q1 		$100M Buy
467,500
+281,100
+151% +$61.7M 0.02% 735
2020
Q4 		$44.1M Buy
186,400
+3,000
+2% +$688K 0.01% 1093
2020
Q3 		$49.9M Sell
183,400
-35,800
-16% -$9.88M 0.01% 865
2020
Q2 		$63.6M Sell
219,200
-110,900
-34% -$30.1M 0.02% 697
2020
Q1 		$78.5M Buy
330,100
+218,600
+196% +$50.1M 0.03% 478
2019
Q4 		$24.4M Sell
111,500
-200,200
-64% -$40.5M 0.01% 1249
2019
Q3 		$52.8M Buy
311,700
+40,600
+15% +$7.18M 0.02% 705
2019
Q2 		$49.7M Buy
271,100
+45,600
+20% +$7.97M 0.02% 689
2019
Q1 		$41.5M Sell
225,500
-601,700
-73% -$111M 0.02% 728
2018
Q4 		$137M Buy
827,200
+330,100
+66% +$57.2M 0.05% 299
2018
Q3 		$95.8M Buy
497,100
+78,300
+19% +$13.9M 0.03% 448
2018
Q2 		$71.2M Buy
418,800
+115,600
+38% +$17.9M 0.02% 523
2018
Q1 		$49.4M Buy
303,200
+4,900
+2% +$800K 0.02% 670
2017
Q4 		$44.7M Sell
298,300
-558,300
-65% -$82.7M 0.02% 746
2017
Q3 		$130M Buy
856,600
+55,200
+7% +$8.31M 0.05% 307
2017
Q2 		$103M Buy
801,400
+330,700
+70% +$39.8M 0.05% 339
2017
Q1 		$51.5M Sell
470,700
-8,100
-2% -$713K 0.03% 569
2016
Q4 		$35.3M Buy
478,800
+128,300
+37% +$10.4M 0.02% 713
2016
Q3 		$30.6M Buy
350,500
+30,000
+9% +$2.84M 0.01% 754
2016
Q2 		$27.6M Buy
320,500
+31,100
+11% +$2.69M 0.01% 795
2016
Q1 		$23M Sell
289,400
-18,200
-6% -$1.65M 0.01% 910
2015
Q4 		$38.7M Buy
307,600
+20,400
+7% +$2.46M 0.02% 736
2015
Q3 		$29.9M Sell
287,200
-86,200
-23% -$11.1M 0.01% 919
2015
Q2 		$46.1M Sell
373,400
-48,200
-11% -$6.07M 0.02% 730
2015
Q1 		$49.7M Sell
421,600
-365,800
-46% -$43.8M 0.02% 632
2014
Q4 		$93.5M Sell
787,400
-92,500
-11% -$10.4M 0.04% 440
2014
Q3 		$98.8M Sell
879,900
-867,000
-50% -$82.5M 0.04% 410
2014
Q2 		$165M Buy
1,746,900
+876,600
+101% +$61.5M 0.07% 230
2014
Q1 		$61.5M Sell
870,300
-134,800
-13% -$10.7M 0.03% 526
2013
Q4 		$74.7M Buy
1,005,100
+151,900
+18% +$10.6M 0.03% 469
2013
Q3 		$64.7M Sell
853,200
-160,700
-16% -$12.8M 0.03% 482
2013
Q2 		$81M Buy
+1,013,900
New +$74.7M 0.05% 334

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group's VRTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Vertex Pharmaceuticals (VRTX) stake by 76% in Q1 2026, selling an estimated $29.8M and leaving 20,221 shares worth $9.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3275.

Susquehanna International Group first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $107M in Q1 2021. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Susquehanna International Group held 20,221 shares of Vertex Pharmaceuticals worth $9.03M as of Q1 2026.
  • Susquehanna International Group sold 63,875 Vertex Pharmaceuticals shares in Q1 2026, an estimated $29.8M.
  • Vertex Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3275 holding.
  • Susquehanna International Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Vertex Pharmaceuticals position peaked at $107M in Q1 2021.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.